| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MPA.0B013E31825DE678 |
| P698 | PubMed publication ID | 23000889 |
| P50 | author | Kazuhiko Koike | Q21699620 |
| Naoki Sasahira | Q74692931 | ||
| Kazumichi Kawakubo | Q82100962 | ||
| P2093 | author name string | Takashi Sasaki | |
| Hideaki Ijichi | |||
| Hiroyuki Isayama | |||
| Kenji Hirano | |||
| Minoru Tada | |||
| Natsuyo Yamamoto | |||
| Yousuke Nakai | |||
| Keisuke Tateishi | |||
| Hirofumi Kogure | |||
| Suguru Mizuno | |||
| P433 | issue | 2 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 202-208 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Pancreas | Q15762014 |
| P1476 | title | Clinical outcomes of chemotherapy for diabetic and nondiabetic patients with pancreatic cancer: better prognosis with statin use in diabetic patients | |
| P478 | volume | 42 |
| Q33407858 | A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. |
| Q36701534 | Angiotensin and systems thinking: wrapping your mind around the big picture |
| Q33598407 | Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis |
| Q38723341 | Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study |
| Q30235047 | Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studies |
| Q36310097 | Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis |
| Q36182971 | Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study |
| Q39238333 | Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis |
| Q36642870 | Impact of Metformin on Advanced Pancreatic Cancer Survival: Too Little, Too Late? |
| Q36927791 | Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer |
| Q36309449 | Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer |
| Q37404368 | Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis |
| Q33648824 | Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis |
| Q52688122 | Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer. |
| Q37617965 | Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer |
| Q36993452 | Statin Use and Its Impact on Survival in Pancreatic Cancer Patients |
| Q33597969 | Statins and pancreatic cancer |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q36482526 | The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy |
| Q35242280 | The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis |
Search more.